Discrimination of resected glioma tissues using surface enhanced Raman spectroscopy and Au@ZrO2 plasmonic nanosensor

Spectrochim Acta A Mol Biomol Spectrosc. 2024 Jan 15:305:123521. doi: 10.1016/j.saa.2023.123521. Epub 2023 Oct 14.

Abstract

Gliomas present one of the most prevalent malignant tumors related to the central nervous system. Surgical extraction is still a preferred route for glioma treatment. Nonetheless, neurosurgeons still have a considerable challenge to detect actual margins of the targeted glioma intraoperatively and correctly because of its great natural infiltration. Here we evaluated the possibility of using surface-enhanced Raman spectroscopy to analyze freshly resected brain tissues. The developed method is based on the application of Au@ZrO2 nanosensor. The plasmonic properties of the sensor were first tested on the analysis of Rhodamine 6G, where concentrations down to 10-7 mol/L can be successfully detected. We also compared the performance of the nanosensor with silver plasmonic nanoparticles, where similar results were obtained regarding the reduction of the fluorescence background and enhancement of the intensity of the measured analytical signal. However, application of silver nanospheres led to increased variations in spectral data due to its probable aggregation. Applied ZrO2@Au nanosensor thus dramatically lowers the fluorescence present in the Raman data, and considerably improves the quality of the measured signal. The developed method allows for rapid discrimination between the glioma's periphery and central parts, which could serve as a steppingstone toward highly precise neurosurgery.

Keywords: Au nanospheres; Gliomas; Nanomaterials; Raman spectroscopy; SERS; ZrO(2).

MeSH terms

  • Glioma*
  • Gold / chemistry
  • Humans
  • Metal Nanoparticles* / chemistry
  • Nanospheres* / chemistry
  • Silver / chemistry
  • Spectrum Analysis, Raman / methods

Substances

  • Silver
  • Gold